Agora news

Company demonstrated strong financial performance with 13.5% YoY revenue growth, sixth consecutive quarter of GAAP profitability, improved net income ($1.1M vs $0.4M YoY), and strong Dollar-Based Net Retention Rate of 99% (up from 95%). Successful product launch of Agent Studio and robust customer adoption support positive momentum. However, gross margin compression (63.4% vs 68.0%) and declining operating cash flow ($5.7M vs $17.6M) present some concerns, but overall trajectory remains positive.

The article is a routine earnings announcement with no forward-looking statements, performance metrics, or qualitative information that would indicate positive or negative business developments. It is purely informational about the timing and logistics of the earnings release.

Strategic partnership expands Agora's platform capabilities into high-value healthcare and safety-critical markets. The integration adds clinically validated health intelligence to their real-time infrastructure, positioning them as a leader in voice-first AI with enterprise-grade compliance (HIPAA, SOC 2, ISO 27001). This opens new revenue streams across multiple industries.

Company achieved fifth consecutive quarter of GAAP profitability and first full year of profitability since 2018. Agora division showed strong 16.1% revenue growth YoY, 109% dollar-based net retention rate, and 21% increase in active customers. Successful Super Bowl event demonstrated platform scalability. However, overall company growth moderated to 5.9% due to Shengwang division decline, and Q1 2026 guidance shows slowing growth momentum at 8.1-11.1% YoY.